These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2975904)

  • 41. The effect of Propionibacterium acnes on maturation of dendritic cells derived from acne patients' peripherial blood mononuclear cells.
    Michalak-Stoma A; Tabarkiewicz J; Olender A; Juszkiewicz-Borowiec M; Stoma F; Pietrzak A; Pozarowski P; Bartkowiak-Emeryk M
    Folia Histochem Cytobiol; 2008; 46(4):535-9. PubMed ID: 19141410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of hyaluronidase by propionibacteria from different origins.
    Höffler U
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):123-9. PubMed ID: 44604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propionibacterium acnes-Derived Extracellular Vesicles Promote Acne-Like Phenotypes in Human Epidermis.
    Choi EJ; Lee HG; Bae IH; Kim W; Park J; Lee TR; Cho EG
    J Invest Dermatol; 2018 Jun; 138(6):1371-1379. PubMed ID: 29409885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced expression of dermcidin, a peptide active against propionibacterium acnes, in sweat of patients with acne vulgaris.
    Nakano T; Yoshino T; Fujimura T; Arai S; Mukuno A; Sato N; Katsuoka K
    Acta Derm Venereol; 2015 Sep; 95(7):783-6. PubMed ID: 25673161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
    Basal E; Jain A; Kaushal GP
    J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J
    Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
    Dessinioti C; Katsambas AD
    Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of an acidic polysaccharide antigen from Propionibacterium acnes.
    Iversen OJ; Dalen AB; Svindland HB
    Arch Dermatol Res; 1985; 277(3):225-9. PubMed ID: 3160311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ
    Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris.
    Mouser PE; Baker BS; Seaton ED; Chu AC
    J Invest Dermatol; 2003 Nov; 121(5):1226-8. PubMed ID: 14708633
    [No Abstract]   [Full Text] [Related]  

  • 51. Acne vaccines: therapeutic option for the treatment of acne vulgaris?
    Kim J
    J Invest Dermatol; 2008 Oct; 128(10):2353-4. PubMed ID: 18787542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
    Kistowska M; Meier B; Proust T; Feldmeyer L; Cozzio A; Kuendig T; Contassot E; French LE
    J Invest Dermatol; 2015 Jan; 135(1):110-118. PubMed ID: 25010142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acne. Current pathophysiologic considerations].
    Degitz K; Ochsendorf F
    Hautarzt; 2008 Jun; 59(6):503-12; quiz 511. PubMed ID: 18488182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propionibacterium species and follicular keratinocyte activation in acneic and normal skin.
    Jahns AC; Eilers H; Ganceviciene R; Alexeyev OA
    Br J Dermatol; 2015 Apr; 172(4):981-7. PubMed ID: 25279837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acne: a new model of immune-mediated chronic inflammatory skin disease.
    Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
    G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory.
    Jappe U; Boit R; Farrar MD; Ingham E; Sandoe J; Holland KT
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):450-4. PubMed ID: 15196160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding innate immunity and inflammation in acne: implications for management.
    Dreno B; Gollnick HP; Kang S; Thiboutot D; Bettoli V; Torres V; Leyden J;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():3-11. PubMed ID: 26059728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.